Enclomiphene, developed by Repros Therapeutics Inc, is a nonsteroidal estrogen receptor antagonist that promotes testosterone secretion by increasing levels of gonadotropin produced by the
LGD-3303, just like its predecessor LGD-4033, is a selective androgen receptor modulator (SARM). Both help the user put on lean muscle mass while increasing
S-23 is a selective androgen receptor modulator (SARM) developed by the pharmaceutical company GTX Inc. S-23 binds to the androgen receptor more effectively than older
LGD-4033 is arguably the most potent SARM currently available. It is currently being developed to improve recovery from hip fractures and combat sarcopenia in elderly
Cardarine, also known as GW-501516, is often labeled as a SARM (Selective Androgen Receptor Modulator) but in fact, it is a PPARδ (Peroxisome proliferator-activated receptor
